| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |